KR101667021B1 - Method for preparing functional pills with nyoa fruticans and functional pills by the method - Google Patents
Method for preparing functional pills with nyoa fruticans and functional pills by the method Download PDFInfo
- Publication number
- KR101667021B1 KR101667021B1 KR1020160051215A KR20160051215A KR101667021B1 KR 101667021 B1 KR101667021 B1 KR 101667021B1 KR 1020160051215 A KR1020160051215 A KR 1020160051215A KR 20160051215 A KR20160051215 A KR 20160051215A KR 101667021 B1 KR101667021 B1 KR 101667021B1
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- flower bud
- ring
- pills
- liquid concentrate
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 17
- 239000006187 pill Substances 0.000 title abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 28
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000001035 drying Methods 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 235000014666 liquid concentrate Nutrition 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000000465 moulding Methods 0.000 claims description 7
- 235000000346 sugar Nutrition 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 241000430525 Aurinia saxatilis Species 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- 241001133760 Acoelorraphe Species 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 abstract description 14
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 10
- 244000004005 Nypa fruticans Species 0.000 abstract description 9
- 235000005305 Nypa fruticans Nutrition 0.000 abstract description 9
- 239000012141 concentrate Substances 0.000 abstract description 7
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 14
- 235000015872 dietary supplement Nutrition 0.000 description 10
- 230000002292 Radical scavenging effect Effects 0.000 description 9
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 6
- 239000002158 endotoxin Substances 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- 229920006008 lipopolysaccharide Polymers 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 241000607184 Nipponia Species 0.000 description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 235000013824 polyphenols Nutrition 0.000 description 5
- 239000011669 selenium Substances 0.000 description 5
- 229910052711 selenium Inorganic materials 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 235000002789 Panax ginseng Nutrition 0.000 description 4
- 240000000851 Vaccinium corymbosum Species 0.000 description 4
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 4
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 235000021014 blueberries Nutrition 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000004889 Interleukin-6 Human genes 0.000 description 3
- 108090001005 Interleukin-6 Proteins 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 241001505935 Phalaenopsis Species 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 3
- 229960003957 dexamethasone Drugs 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- QCHPKSFMDHPSNR-UHFFFAOYSA-N 3-aminoisobutyric acid Chemical compound NCC(C)C(O)=O QCHPKSFMDHPSNR-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 235000019784 crude fat Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000013681 dietary sucrose Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 229940100601 interleukin-6 Drugs 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- 241000383638 Allium nigrum Species 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- YPWSLBHSMIKTPR-UHFFFAOYSA-N Cystathionine Natural products OC(=O)C(N)CCSSCC(N)C(O)=O YPWSLBHSMIKTPR-UHFFFAOYSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- ILRYLPWNYFXEMH-UHFFFAOYSA-N D-cystathionine Natural products OC(=O)C(N)CCSCC(N)C(O)=O ILRYLPWNYFXEMH-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000003777 Interleukin-1 beta Human genes 0.000 description 1
- 108090000193 Interleukin-1 beta Proteins 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- ILRYLPWNYFXEMH-WHFBIAKZSA-N L-cystathionine Chemical compound [O-]C(=O)[C@@H]([NH3+])CCSC[C@H]([NH3+])C([O-])=O ILRYLPWNYFXEMH-WHFBIAKZSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 244000018764 Nyssa sylvatica Species 0.000 description 1
- 235000003339 Nyssa sylvatica Nutrition 0.000 description 1
- SUHOOTKUPISOBE-UHFFFAOYSA-M O-phosphonatoethanaminium(1-) Chemical compound [NH3+]CCOP([O-])([O-])=O SUHOOTKUPISOBE-UHFFFAOYSA-M 0.000 description 1
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 244000304393 Phlox paniculata Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241000120622 Rhizophoraceae Species 0.000 description 1
- 240000005499 Sasa Species 0.000 description 1
- 240000006661 Serenoa repens Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 210000001099 axilla Anatomy 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- KNMNNEPMKDJBDW-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCNC(C)COC1=C(C)C=CC=C1C KNMNNEPMKDJBDW-UHFFFAOYSA-N 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- -1 that is Substances 0.000 description 1
- 238000009461 vacuum packaging Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1568—Gold
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Abstract
Description
The present invention relates to a method for producing a functional ring using nipaya and a functional ring thereof, and more particularly, to a method for producing a functional ring using nipaya as a nutritional supplement, And a functional ring thereof.
In general, it is not surprising that anyone who wants to live a healthy life without disease.
However, modern people are suffering from the immaturity of the human body due to heavy work, excessive drinking, overwork, irregular eating, lack of exercise, stress, pollution and other external environmental factors. Such a decrease in the immune function of the human body is a problem directly related to health.
As described above, according to the decline of the immune function, modern people living in the modern world are taking all kinds of measures to improve the immunity of the human body in preparation for the right of health and the abnormality of health that may occur in the future. In addition to investment, there is also a lot of spending on the economic side.
The most active effort by modern people to improve the body 's immunity is to take exercise and health supplements. These exercises and health supplements are most often used as a means of maintaining health because they are less time and economic burdens than others.
Especially, in the case of health supplements, many kinds of things are around our life, so they can be taken according to their health condition or taste. These health supplements are intended to be used for the purpose of consuming in the physical and physiological aspects of the body, in order to consume the ingredients contained in the food material as they are, or to separate or extract specific components contained therein, concentrate, refine, Which is manufactured and processed.
However, most of these health supplements are distributed in the market as liquid vacuum packs, and many inconveniences are involved in taking and carrying them. In particular, people who do not like liquids have difficulties in taking them, and even when carrying them, liquid-phase vacuum packaging is subject to many restrictions.
Therefore, in order to solve such a problem, circulation type health supplement foods have been released, thereby solving the inconvenience of taking or the inconvenience of carrying.
As the above-mentioned annular health supplement food, there are the following conventional techniques.
First, Korean Patent No. 10-0705740 proposes a method of molding a lactic acid bacterium and a cheonggukjang into a ring using a ventilator and drying to produce a functional ring. Korean Patent No. 10-1083458 proposes a method for producing a ring containing black garlic as an active ingredient and suggests a method for producing a ring by mixing black gum, Respectively. Korean Patent No. 10-1552389 proposes a method of manufacturing a ring using ginger and bamboo salt.
All of the above-mentioned manufacturing methods have solved the inconvenience of taking and carrying.
However, none of the above prior arts have found an example of producing a ring using nipaya.
Accordingly, an object of the present invention is to provide an antioxidative and anti-inflammatory effect by producing a ring using a liquid concentrate and flower bud of NiPhaya.
It is also an object of the present invention to replace the use of steroid drugs.
In order to accomplish the above object, the present invention provides a functional ring using nipaya, comprising the steps of: preparing a nipah yam liquid concentrate; preparing a nipaya flower bud as a powder; and adding the prepared liquid concentrate and nipaya flower powder Mixing the mixture to form a mixture; molding the mixed mixture into a circle; applying edible gold powder to the surface of the formed ring; and drying the ring coated with the gold powder. do.
The step of preparing the nipponia saliva liquid concentrate is characterized in that the sap is obtained from the nipponia palmarium and the resulting sap is heated at 60 to 80 ° C for 2 to 4 hours to be concentrated to have a sugar content of 60 to 80 brix.
The step of making the flower bud of the nepalaya as powder comprises the steps of cutting the flower bud of nifaya, the step of tipping the flower bud of the cut nifaya into boiling water, drying the flower bud of the nepaya flower, And pulverizing the flower bud of the dried nipayanas.
The mixing of the prepared liquid concentrate and the powder is characterized in that the liquid concentrate and the powder are mixed at a weight ratio of 1: 0.5 to 1.5.
And the flower bud is made into a powder together with the flower bud of Nipaya.
The functional ring according to the present invention is characterized by being manufactured by the above-described methods.
According to the present invention, an antioxidative activity and an anti-inflammatory effect of a liquid concentrate, a flower bud, etc. of NiPhaya have an advantage of helping the health of the consumer.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a process flow diagram for the production of a functional ring using nipahazite according to the present invention. Fig.
2 to 5 are graphs showing the results according to Test Example 2 of the present invention.
Hereinafter, the present invention will be described in detail.
The functional ring of the present invention has antioxidant and anti-inflammatory effects, and has an effect of imparting excellent antioxidative and anti-inflammatory properties to the human body just by ingesting the ring as a health supplement.
Such a functional ring of the present invention is prepared using nipaya.
Here, the Nypa fruticans originate in India, Malaysia, Southeast Asia and Australia, and grow in wetlands such as mangroves. The roots are divided into several pieces in the ground, and the leaves are gathered on the ground and have glossy green. And the flower is one male and one female, and it comes out from the axilla of the ground. Usually, the flower stands rise from October to June of the following year.
The reason for using the flower buds of Nipaya is that it has abundant antioxidant components such as polyphenols in the flower bud than any other part of Nipaya, Selenium and other nutritional components, as well as show excellent anti-inflammatory effect.
The results of the analysis and the results of the components of the above-mentioned Nihonpalaceae are shown in the following Tables 1 and 2. As shown in Table 1 and Table 2, the Niha-Paya's peduncle contains a large amount of effective components such as polyphenol, flavonoid, saponin, as well as aspartic acid, tyrosine and histidine .
Therefore, when a functional ring is manufactured using such a nifa palm phlox, it has an excellent antioxidant ability, and has an anticancer effect through selenium or the like, and gives a beneficial effect to the human body.
The method for producing a functional ring according to the present invention comprises the steps of preparing a nipponia liquor concentrate, preparing a flower bud of nifayja as a powder, mixing the prepared liquid concentrate and a nifana phalaenopsis powder, , Molding the mixed mixture into a circle, applying edible gold powder to the surface of the formed ring, and drying the ring coated with the gold powder.
Hereinafter, the present invention will be described step by step with reference to Fig.
Nipa Preparing a liquid concentrate.
First, prepare a liquid concentrate of NiPhaya. The liquid concentrate is obtained by concentrating the liquid. When a wound is formed on the top of a nipahaya phalaenopsis, and a wounded area is covered with a plastic bag or the like, 500 to 700 g of liquid per one night can be obtained. The liquid is heated at about 60 to 80 ° C for about 2 to 4 hours to be concentrated to have a sugar content of 60 to 80 brix.
This nipah sasa liquid concentrate is dark brown in color and can feel a bitter but strong sweet taste. In addition, as shown in Tables 3 and 4, selenium having various anticancer effects as well as a large amount of polyphenols and various effective ingredients are included, thereby helping the health of the recipient.
Nipaya The step of preparing the flower bud as a powder.
Separately from the preparation of the above-mentioned liquid concentrate, the flower bud of Nipaya is made into powder. The method comprises the steps of cutting a flower bud of Nipaya, a step of putting the flower bud of the cut Nipaya flower into boiling water, drying the flower bud of the flavored Nipaya flower, pulverizing the dried flower bud of Nipaya flower, .
To describe this in detail, first, a flower bud of a nippi is picked up and cut into a length of 3 to 10 cm and a width of about 1 cm. Then, cut the peduncle into boiling water, that is, water at 100 ° C for 2 to 10 minutes. Then, it is dried so as to have a moisture content of 10% or less, preferably 5 to 10%. At this time, as the drying method, hot air drying, cold air drying, natural drying, or the like can be used. Finally, the dried flower bud is pulverized to about 200 to 300 mesh by a pulverizer.
Here, it is natural that the present invention can be used as it is without removing the buds formed on the flower buds, since the flower buds of Nepalaya are used and the flower buds of Nepalaya contain a large amount of human beneficial ingredients.
Mixing the prepared liquid concentrate and the powder.
Next, the prepared liquid concentrate and powder are mixed at a weight ratio of 1: 0.5 to 1.5, most preferably 1: 1. If the content of the powder is too small, molding into the ring is difficult and the drying time becomes long. If the content of the powder is too large, the formed ring easily collapses due to the lack of adhesiveness. Is most preferable.
And molding the mixed mixture into a circle.
And the mixed mixture is molded into a ring. The method of molding into a ring uses a conventionally known method, that is, a ventilator or the like, and does not limit the size of the ring, that is, the diameter of the ring.
remind Molded Applying the edible gold powder to the surface of the ring.
Next, the edible gold powder is applied to the surface of the formed ring.
The edible gold powder uses commercially available products and does not limit the particle size thereof. In the present invention, the edible gold powder is easily adhered to the surface of the formed ring because of the stickiness of the liquid concentrate. Therefore, it is possible to apply only by spraying the edible gold powder onto the surface of the ring.
The use amount of the edible gold powder is not limited, but it is sufficient that the gold powder is evenly applied on the surface.
The reason for applying the edible gold powder on the surface of the formed ring in the present invention is to enhance the appearance of the edible gold powder to enhance the merchantability and help the heavy metal accumulated in the body to be discharged.
Drying the ring coated with the gold dust.
Finally, the ring coated with the gold dust is dried. At this time, the drying method uses natural drying and cold air drying.
The functional ring of the present invention produced by the above-mentioned method has excellent antioxidant and anti-inflammatory ability, and thus helps the health of the consumer.
The functional ring of the present invention is a health supplement, and its intake amount is not limited, but it is preferable to ingest 1 ring / day of a ring formed with a diameter of 0.7 to 1 cm.
Hereinafter, the present invention will be described in more detail with reference to specific examples.
(Production Example 1)
First, the nipponia palms were picked, cleaned and then cut into 10 cm lengths and 1 cm widths. Then, it was boiled in boiling water at 100 ° C for 3 minutes. Then, the mixture was naturally dried to have a moisture content of 7%, and then pulverized by a pulverizer to prepare a 200-mesh powder.
(Test Example 1)
Evaluation of Antioxidative Capacity of.
The antioxidative capacity of the nifalcaya peduncle prepared in Preparation Example 1 was measured.
(1) Extraction of sample
The ethanol extract of the sample was prepared by adding 95% ethanol of 9 times the amount of the sample (w / v), firstly extracting it with stirring at room temperature for 1 week using an automatic stirrer, and filtering paper (Advantec No. 2, Toyo Roshi Kainshm. , Tokyo, Japan), and concentrated under reduced pressure at 40 ° C in a rotary vacuum evaporator (EYELAA-1000S, Tokyo Rikakikai Co., Tokyo, Japan).
(2) Measurement of DPPH radical scavenging ability
To determine the antioxidant activity, the Biois method was used to examine the radical scavenging effect of DDPH (1,1-diphenyl-2-picryhydrazyl, Sigma-Aldrich Co.). 1 ml of 0.2 mM DPPH was added to 1 ml of the sample solution prepared from 0.625 to 10 mg / ml of each extract, mixed using a vortex mixer, reacted for 30 minutes in a dark room, and absorbance was measured at 517 nm. Then, free radical scavenging activity curves were generated using the following equation, and IC 50 was calculated. As a positive control, ascorbic acid was used.
Radical scavenging activity (%) = {(control Absorbance - Sample Absorbance) / control Absorbance} × 100
(3) Measurement of ABTS radical scavenging ability
ABTS radical scavenging activity was measured by Pellegrin et al. 5 ml of 7 mM ABTS (2,2'-azinobis (3-ethylenbenzothiazoline-6-sulfonate), Sigma-Aldrich Co.) and 88 μl of 140 mM K 2 S 2 O 8 (Sigma-Aldrich Co.) .
The mixture was mixed with absolute ethanol at a ratio of 1:88, and the ABTS solution was prepared so that the absorbance of the control was adjusted to 0.7 ± 0.002 at 734 nm. 1 ml of ABTS solution was added to 50 μl of the sample solution, and the mixture was allowed to stand in a dark room for 2.5 minutes, and the absorbance was measured at 734 nm.
The results are shown in Tables 5 and 6 below.
(mg / ml)
(mg.ml)
0.125
0.0625
0.03125
0.15625
51.52 ± 1.09
26.74 1.51
13.93 ± 2.09
7.82 + - 0.37
0.5
0.25
0.125
0.0625
44.73 + - 0.74
36.62 ± 0.49
30.87 + - 0.41
28.79 + - 0.41
0.5
0.25
0.125
0.0625
37.41 + - 0.41
32.67 + - 0.43
30.27 + - 0.14
28.98 + - 0.43
The IC 50 value represents the concentration of the extract which reduces the value of the control without the extract by 50%. The smaller the IC 50 value, the higher the antioxidant activity. Therefore, as shown in Table 5, according to DPPH radical scavenging activity measurement results, the antioxidant activity of Nypha palmaxil was about 40 times higher than that of blueberry and about 75 times higher than that of red ginseng.
(mg / ml)
(mg.ml)
0.125
0.0625
0.03125
0.15625
23.28 ± 0.99
11.54 + - 0.94
5.87 ± 0.27
2.50 ± 0.56
0.5
0.25
0.125
0.0625
10.05 + 0.48
5.40 ± 0.17
3.12 ± 0.15
2.08 ± 0.59
0.5
0.25
0.125
0.0625
6.09 ± 0.51
3.02 ± 0.31
1.58 ± 0.56
0.25 0.31
As shown in Table 6, according to the result of ABTS radical scavenging activity measurement, the antioxidant activity of the Nihonpalaceae was about 42 times higher than that of blueberry and about 59 times higher than that of red ginseng.
(Test Example 2)
Anti - Inflammatory Effects of.
The anti-inflammatory effect of the Nihonpalaceae prepared as in Preparation Example 1 was measured.
IL-1β (interleukin-1beta), IL-6 (interleukin-6, interleukin-6) and TNF-α (tumor necrosis factor-alpha, Or tumor necrosis factor-alpha).
The test method was to investigate whether inflammation was induced by macrophages using LPS (lipopolysaccharide) and the general inflammation index was suppressed when the sample was treated with LPS (lipopolysaccharide). As a positive control, DEX (Dexamethasone) was used as a comparative drug. The sample was prepared by adding a 1: 5 volume ratio of the nifedowana phalaenopsis powder prepared in Preparation Example 1 and water at a temperature of 60 to 80 DEG C for 48 hours to prepare a hot water extract. The extract was freeze- After the preparation, it was diluted to the concentration.
The results are shown in Figs. 2 to 5. Fig.
As can be seen from FIG. 2, Nitrite was significantly increased upon induction of inflammation by LPS, but Nitrite increased due to treatment of NIPHACA.
As can be seen from FIGS. 3, 4 and 5, cytokine was significantly increased upon induction of inflammation induced by LPS, but it was confirmed that the inflammation was alleviated by the treatment of Nephala palmetto.
Therefore, it was judged that the stamen of the nipponeya had an inhibitory effect on inflammatory factors in a concentration-dependent manner and a suppressive effect similar to DEX known as an anti-inflammatory component.
(Example 1)
In the same manner as in Preparation Example 1, a flower bud of NiPhaya was prepared as a powder. Then, the nipahaxa solution concentrate was wounded on the upper part of the phloem of nipaya, which was wrapped in a plastic bag to obtain a solution overnight, followed by concentrating by heating at 70 ° C for 3 hours. At that time, the sugar content was 71brix.
The prepared powder and the liquid concentrate were mixed at a weight ratio of 1: 1, and the mixture was molded into a circle having a diameter of 0.7 cm. Then, the surface of the powder was coated with edible gold powder. And dried in cold air (5 ° C) for 1 hour.
(Test Example 3)
The taste, aroma, appearance, and overall acceptability of the 20 sensory evaluation personnel trained in the rings prepared in Example 1 were evaluated by the 9-point scale method (1: very bad, 9: very good) The average value is shown in Table 1 below. The control was purchased and compared with the commercially available Cheonggukjang.
As shown in Table 7, it was confirmed that Example 1 of the present invention had higher taste, smell, appearance, and overall acceptability than the control. It was judged that the palatability and flavor of nipaya was felt during ingestion and the degree of preference increased.
While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the scope of the present invention is not limited to the disclosed exemplary embodiments. It will also be appreciated that many modifications and variations will be apparent to those skilled in the art without departing from the scope of the invention.
Claims (7)
Preparing a flower bud of nifayja as a powder,
Mixing the prepared liquid concentrate and the powder,
Molding the mixed mixture into a circle;
Applying edible gold powder to the surface of the shaped ring,
Drying the ring to which the gold dust is applied,
Wherein the step of preparing the nipahyal liquid concentrate comprises:
Comprising the steps of: obtaining a sap from a palm tree, heating the obtained sap at 60 to 80 DEG C for 2 to 4 hours to obtain a sugar content of 60 to 80 brix,
The step of producing the flower bud of nifayja as a powder comprises:
A step of cutting a flower bud of nipaya,
Placing the cut flower of the nippae in boiling water,
Drying the spikelets of the poached nepalese,
And crushing the dried flower bud of the nippae,
In the step of mixing the prepared liquid concentrate and powder,
The liquid concentrate and the powder are mixed at a weight ratio of 1: 0.5 to 1.5,
A method for producing a functional ring using a nipponja, the method comprising drying the beaked peduncle to a moisture content of 5 to 10%.
In the step of producing the flower bud of nifayja as a powder,
Wherein the flower bud is produced as a powder together with the flower bud of the nifayja.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160051215A KR101667021B1 (en) | 2016-04-27 | 2016-04-27 | Method for preparing functional pills with nyoa fruticans and functional pills by the method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160051215A KR101667021B1 (en) | 2016-04-27 | 2016-04-27 | Method for preparing functional pills with nyoa fruticans and functional pills by the method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101667021B1 true KR101667021B1 (en) | 2016-10-20 |
Family
ID=57251357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160051215A KR101667021B1 (en) | 2016-04-27 | 2016-04-27 | Method for preparing functional pills with nyoa fruticans and functional pills by the method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101667021B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101820531B1 (en) | 2016-12-07 | 2018-02-28 | 농업회사법인 주식회사 토디팜코리아 | Composition for preventing hair loss or promoting hair growth with Nipa fruticans wurmb |
KR101847132B1 (en) * | 2017-01-31 | 2018-04-12 | 배대열 | Food additives with nipa fruticans wurmb nad method for prolonging preservation of meat products using thereof |
KR20180065419A (en) * | 2016-12-07 | 2018-06-18 | 배대열 | Composition for anti-inflammation with nipa fruticans wurmb |
KR20180082931A (en) * | 2017-01-11 | 2018-07-19 | 농업회사법인주식회사니파바이오 | Funtional underwear with nipa fruticans wurmb |
KR101891809B1 (en) * | 2017-01-24 | 2018-08-24 | 농업회사법인주식회사니파바이오 | Manufacturing method of scorched rice snack with nipa fruticans wurmb and scorched rice snack by the method |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100705740B1 (en) | 2006-06-13 | 2007-04-09 | 정주양 | Manufacturing process of pill-type cheonggukjang |
KR20110108654A (en) * | 2010-03-29 | 2011-10-06 | 김진우 | Health food with myrrh and its manufacturing method |
KR101083458B1 (en) | 2009-06-30 | 2011-11-16 | 경남도립남해대학 산학협력단 | Preparation method of bioactive pill of aged black garlic showing improving effects on hyperglycemia and insulin resistance |
KR20150012725A (en) * | 2013-07-26 | 2015-02-04 | 강동연 | Vinegar with Garlic Bead using Barren land Germanium Bamboo Salt and Method for the Same |
-
2016
- 2016-04-27 KR KR1020160051215A patent/KR101667021B1/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100705740B1 (en) | 2006-06-13 | 2007-04-09 | 정주양 | Manufacturing process of pill-type cheonggukjang |
KR101083458B1 (en) | 2009-06-30 | 2011-11-16 | 경남도립남해대학 산학협력단 | Preparation method of bioactive pill of aged black garlic showing improving effects on hyperglycemia and insulin resistance |
KR20110108654A (en) * | 2010-03-29 | 2011-10-06 | 김진우 | Health food with myrrh and its manufacturing method |
KR20150012725A (en) * | 2013-07-26 | 2015-02-04 | 강동연 | Vinegar with Garlic Bead using Barren land Germanium Bamboo Salt and Method for the Same |
KR101552389B1 (en) | 2013-07-26 | 2015-09-10 | 강동연 | Vinegar with Garlic Bead using Barren land Germanium Bamboo Salt and Method for the Same |
Non-Patent Citations (1)
Title |
---|
Lim T. K., Edible Medicinal and Non-Medicinal Plants. Vol. 1, Fruits, Chapter 50, Nipa Fruticans, pp402-406, 2011.09.29.* * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101820531B1 (en) | 2016-12-07 | 2018-02-28 | 농업회사법인 주식회사 토디팜코리아 | Composition for preventing hair loss or promoting hair growth with Nipa fruticans wurmb |
KR20180065419A (en) * | 2016-12-07 | 2018-06-18 | 배대열 | Composition for anti-inflammation with nipa fruticans wurmb |
KR101879685B1 (en) | 2016-12-07 | 2018-08-17 | 농업회사법인주식회사니파바이오 | Composition for anti-inflammation with nipa fruticans wurmb |
KR20180082931A (en) * | 2017-01-11 | 2018-07-19 | 농업회사법인주식회사니파바이오 | Funtional underwear with nipa fruticans wurmb |
KR101891809B1 (en) * | 2017-01-24 | 2018-08-24 | 농업회사법인주식회사니파바이오 | Manufacturing method of scorched rice snack with nipa fruticans wurmb and scorched rice snack by the method |
KR101847132B1 (en) * | 2017-01-31 | 2018-04-12 | 배대열 | Food additives with nipa fruticans wurmb nad method for prolonging preservation of meat products using thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101662779B1 (en) | Method for preparing functional tea with nipa fruticans wurmb and functional tea by the method | |
KR101667021B1 (en) | Method for preparing functional pills with nyoa fruticans and functional pills by the method | |
CN103168887A (en) | Method for preparing maca tea bag | |
KR101710507B1 (en) | Powder like food composition with nipa fruticans wurmb | |
KR20120079943A (en) | Powder sauce and process thereof | |
KR101256744B1 (en) | Hot sauce and process thereof | |
KR101710518B1 (en) | Method for preparing functional pills with nyoa fruticans and jaggery, and functional pills by the method | |
CN107549613A (en) | A kind of edible wild herbs dumpling and preparation method | |
KR20120079939A (en) | Mixed sauce and process thereof | |
KR20190018842A (en) | Dough composition for noodle cooking containing Vegetable juice | |
KR20200123311A (en) | Functional rice cake with cancer preventive effect and method for producing the same | |
KR20170058518A (en) | Method for producing fermented Moringa oleifera powder with increased amino acid content | |
CN105053319A (en) | Red date abelmoschus esculentus fruit tea beverage | |
KR101233133B1 (en) | Seasoned laver with ramie and manufacturing method thereof | |
KR101710189B1 (en) | Dough composition with nipa fruticans wurmb and method for preparing thereof | |
KR101710191B1 (en) | Method for preparing kimche with nipa fruticans wurmb | |
CN108719559A (en) | A kind of Periostracum cicadae nougat and preparation method thereof | |
KR101712453B1 (en) | Method for preparing bean curd with nipa fruticans wurmb and bean curd by the method | |
KR102082115B1 (en) | Manufacturing method of healthy foods using protaetia brevitarsis | |
KR20170053536A (en) | Beverages for preventing respiratory disease and hyperlipidemia containing Platycodon grandiflorum and its preparing method | |
Mamatha et al. | Formulation of iron fortified masala powders and assessment of nutritional and sensory qualities | |
KR101774501B1 (en) | Dough composition with nipa fruticans wurmb and method for preparing thereof | |
KR101773251B1 (en) | The manufacturing method of making healthcare compositions comprising fermented Cudrania tricuspidata extracts and herbal medicines Abalone extracts | |
KR101237058B1 (en) | Flavored Laver Using Salt with Houttuynia cordata Thunb. Ingredient and the Manufacturing Method | |
JP3019954B2 (en) | Coating material and processed food using it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |